Published on 27 Feb 2024 on Benzinga
Shares of TransMedics Group, Inc. TMDX rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance.
The company posted quarterly earnings of 12 cents per share, compared to market estimates for a loss of 3 cents per share. The company’s quarterly sales came in at $81.17 million versus expectations of $68.51 million.